Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.04 USD | -0.69% | -5.49% | -11.37% |
May. 09 | Earnings Flash (INMB) INMUNE BIO Reports Q1 Revenue $14,000 | MT |
May. 09 | Transcript : INmune Bio, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.37% | 200M | |
+9.81% | 118B | |
+10.02% | 106B | |
-11.93% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.67% | 15.97B | |
+6.19% | 14.03B | |
+14.70% | 11.67B |
- Stock Market
- Equities
- INMB Stock
- News INmune Bio, Inc.
- BTIG Adjusts INmune Bio's Price Target to $14 From $31, Reiterates Buy Rating